Biocristin AQ 1mg Injection

Biocristin AQ 1mg Injection is a chemotherapy medication containing vincristine sulphate as its active ingredient. This medicine belongs to the vinca alkaloid class of drugs, which work by inhibiting cancer cell growth. It is indicated for the treatment of blood, head, breast, neck, kidney, bone, and lung cancers. It is used in treating rhabdomyosarcoma (cancer affecting muscle tissue) and neuroblastoma (cancer developing from immature nerve cells). It may also be prescribed for multiple myeloma (cancer of plasma cells), thyroid cancer, and idiopathic thrombocytopenic purpura (ITP), a blood disorder. Cancer is a condition characterised by uncontrolled and abnormal cell multiplication. This chemotherapy medicine should not be used in patients with untreated infections or Charcot-Marie-Tooth syndrome (a disorder causing weakness in leg muscles). Inform your physician if you have breathing difficulties, mental health conditions, liver disorders, low blood cell counts, nervous system disorders, or are undergoing radiotherapy prior to receiving Biocristin AQ 1mg Injection. As with all chemotherapy drugs, it may cause side effects including nausea, vomiting, constipation, hair loss, and fatigue. Patients with cancer should discuss the potential benefits and risks of treatment with their doctor.

Biocristine AQ 1mg Injection used in the treatment of Cancers of blood, head, neck, breast, kidney, bone, or lung Idiopathic thrombocytopenic purpura (ITP) Multiple myeloma Rhabdomyosarcoma Thyroid cancer Neuroblastoma

The therapeutic effect of Biocristine AQ 1mg Injection is to inhibit the growth and spread of cancer cells. It disrupts the formation and function of microtubules, which are structures inside cells that help with cell division and movement. By interfering with microtubule function, this medication can prevent cancer cells from dividing and multiplying and can also cause them to die.

Biocristine AQ 1mg Injection is usually administered through intravenous injection (IV) by a healthcare professional in a hospital or clinical setting. It should not be taken orally or applied topically to the skin. If you miss a dose, then do not double the dose to make up for the missed one.

Like all medications, Biocristine AQ 1mg Injection Injection can cause side effects, although not everyone who takes it will experience them. Serious: Severe allergic reactions Pulmonary toxicity (lung damage) Liver toxicity Neurotoxicity (damage to the nervous system) Tumor lysis syndrome (life-threatening complication in which cancer cells release their contents into the bloodstream) Common: Nausea and vomiting Constipation Loss of appetite Hair loss Fatigue Muscle weakness Numbness or tingling in the hands and feet (peripheral neuropathy) Increased risk of infection Easy bruising or bleeding Mouth sores Changes in mood or behavior Difficulty sleeping

If you are receiving Biocristine AQ 1mg Injection, it's important to be proactive in managing your treatment and monitoring your symptoms. Keep a close line of communication with your healthcare provider and report any concerns or side effects as soon as possible. Avoid getting pregnant and breastfeeding during treatment. Take steps to care for yourself physically and emotionally during treatment, and seek support from loved ones and professionals as needed. Maintain a healthy and balanced diet during treatment to support your overall health and well-being. By being informed and engaged in your treatment, you can help ensure the best possible outcomes and manage any potential risks or complications.